We use cookies to optimize our website. These include cookies that are necessary for the operation of the site, as well as those that are only used for anonymous statistic. You can decide for yourself which categories you want to allow. Further information can be found in our data privacy protection .

Essential enable/disable

These cookies are necessary to run the core functionalities of this website and cannot be disabled.

Name	Webedition CMS
Purpose	This cookie is required by the CMS (Content Management System) Webedition for the system to function correctly. Typically, this cookie is deleted when the browser is closed.
Name	econda
Purpose	Session cookie emos_jcsid for the web analysis software econda. This runs in the “anonymized measurement” mode. There is no personal reference. As soon as the user leaves the site, tracking is ended and all data in the browser are automatically deleted.

Statistics enable/disable

These cookies help us understand how visitors interact with our website by collecting and analyzing information anonymously. Depending on the tool, one or more cookies are set by the provider.

Name	econda
Purpose	Statistics

External media enable/disable

Content from external media platforms is blocked by default. If cookies from external media are accepted, access to this content no longer requires manual consent.

Name	YouTube
Purpose	Show YouTube content
Name	Twitter
Purpose	activate Twitter Feeds

Research

Thomas Hielscher

Position:

Scientist

Contact:

Contact Form

Phone:

+49 6221 42 2386

Fax:

+49 6221 42 2397

Building:

TP 4

Room:

S4.227

Area of Work

Analysis of prospective and retrospective studies, high-dimensional genomic data, survival data, clinical trials

Education and Background

DKFZ/Biostatistics since May 2007
2004-2007 clinical trial statistician in pharmaceutical industry
Diploma, Statistics, University of Dortmund, 2004

Selected Publications

Merz M, Hielscher T, Wagner B, Sauer S, Shah S, Raab MS, Jauch A, Neben K, Hose D, Egerer G, Weber MA, Delorme S, Goldschmidt H, Hillengass J: Predictive value of longitudinal whole-body magnetic resonance imaging in patients with smoldering multiple myeloma. Leukemia 28, 1902-1908, 2014.
Neben K, Jauch A, Hielscher T, Hillengass J, Lehners N, Seckinger A, Granzow M, Raab MS, Ho AD, Goldschmidt H, Hose D: Progression in Smoldering Myeloma Is Independently Determined by the Chromosomal Abnormalities del(17p), t(4;14), Gain 1q, Hyperdiploidy, and Tumor Load. Journal of Clinical Oncology 31 (34), 4325-4332, 2013.
Remke M*, Hielscher T*, Korshunov A, Northcott PA, Bender S, Kool M, Westermann F, Benner A, Cin H, Ryzhova M, Sturm D, Witt H, Haag D, Toedt G, Wittmann A, Schoettler A von Bueren AO, von Deimling A, Rutkowski S, Scheurlen W , Kulozik AE, Taylor MD, Lichter P, Pfister SM.: FSTL5 is a marker of poor prognosis in non-WNT/ non-SHH medulloblastoma. Journal of Clinical Oncology 29 (29), 3852-3861, 2011. (*joint first authors)
Hielscher T*, Zucknick M*, Werft W, Benner A: On the prognostic value of survival models with application to gene expression signatures. Statistics in Medicine 29 (7-8), 818-829, 2010. (*joint first authors)
Benner A, Zucknick M , Hielscher T, Ittrich C, Mansmann U: High-Dimensional Cox Models: The Choice of Penalty as Part of the Model Building Process. Biometrical Journal 52 (1), 50-69, 2010.

PubMed

Google Scholar